- Home
- LEGN vs LEVI Comparison
LEGN vs LEVI Comparison
Compare LEGN & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- LEVI
- Stock Information
- Founded
- LEGN 2014
- LEVI 1853
- Country
- LEGN United States
- LEVI United States
- Employees
- LEGN N/A
- LEVI N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- LEVI Apparel
- Sector
- LEGN Health Care
- LEVI Consumer Discretionary
- Exchange
- LEGN Nasdaq
- LEVI Nasdaq
- Market Cap
- LEGN 7.0B
- LEVI 6.8B
- IPO Year
- LEGN 2020
- LEVI 2019
- Fundamental
- Price
- LEGN $39.70
- LEVI $18.40
- Analyst Decision
- LEGN Strong Buy
- LEVI Buy
- Analyst Count
- LEGN 12
- LEVI 11
- Target Price
- LEGN $79.50
- LEVI $21.27
- AVG Volume (30 Days)
- LEGN 976.3K
- LEVI 2.5M
- Earning Date
- LEGN 03-10-2025
- LEVI 04-02-2025
- Dividend Yield
- LEGN N/A
- LEVI 2.83%
- EPS Growth
- LEGN N/A
- LEVI N/A
- EPS
- LEGN N/A
- LEVI 0.52
- Revenue
- LEGN $520,183,000.00
- LEVI $6,355,300,000.00
- Revenue This Year
- LEGN $121.13
- LEVI $1.58
- Revenue Next Year
- LEGN $65.25
- LEVI $4.60
- P/E Ratio
- LEGN N/A
- LEVI $35.37
- Revenue Growth
- LEGN 122.96
- LEVI 2.85
- 52 Week Low
- LEGN $30.17
- LEVI $15.62
- 52 Week High
- LEGN $70.13
- LEVI $24.34
- Technical
- Relative Strength Index (RSI)
- LEGN 64.82
- LEVI 52.96
- Support Level
- LEGN $34.36
- LEVI $17.70
- Resistance Level
- LEGN $36.39
- LEVI $18.83
- Average True Range (ATR)
- LEGN 1.67
- LEVI 0.57
- MACD
- LEGN 0.34
- LEVI -0.04
- Stochastic Oscillator
- LEGN 94.68
- LEVI 42.94
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.